• Structural Insights into FADD-Procaspase-8-cFLIP Complex Ass

  2026-06-30

  This study provides the first atomic-resolution structures of human FADD-procaspase-8-cFLIP complexes, elucidating the mechanisms of death-effector domain (DED) assembly in apoptosis and necroptosis regulation. These insights advance understanding of how these complexes fine-tune cell fate decisions, with implications for cancer research targeting apoptotic pathways.

• AI-10-49: Precision CBFβ-SMMHC Inhibitor for AML Research

  2026-06-30

  AI-10-49, a potent CBFβ-SMMHC inhibitor, enables targeted disruption of leukemia-driving fusion proteins, restoring RUNX1 activity in acute myeloid leukemia research. Integrating high specificity and robust in vitro and in vivo activity, it unlocks advanced experimental workflows for dissecting leukemogenic transcriptional programs.

• Ibotenic Acid: Advancing Neurodegenerative Disease Modeling

  2026-06-29

  Explore how ibotenic acid, a dual NMDA and metabotropic glutamate receptor agonist, is redefining neurodegenerative disease modeling and pain circuit research. This article delivers mechanistic insights, strategic guidance for translational neuroscience, and highlights APExBIO’s high-purity ibotenic acid as a pivotal research tool.

• Quinolone–Coumarin Hybrids and Novobiocin Against T. gondii

  2026-06-29

  This study introduces quinolone–coumarin hybrids derived from fluoroquinolones and Novobiocin as promising antiparasitic agents against Toxoplasma gondii. The findings highlight their superior selectivity and reduced cytotoxicity compared to standard therapies, providing a potential new direction for anti-Toxoplasma drug development.

• Metabolic Intervention Enhances Ferroptosis and Cuproptosis

  2026-06-28

  This study introduces a nanosystem-based metabolic intervention that synchronously sensitizes tumor cells to ferroptosis and cuproptosis by inhibiting glycolysis and NAD+ metabolism. The approach enhances anti-tumor immunity and demonstrates a promising strategy for regulated cell death-based cancer therapies.

• GKT137831: Precision Nox1/Nox4 Inhibition for Redox and Ferr

  2026-06-27

  Explore the mechanistic depth of GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor, in oxidative stress and ferroptosis research. This article uniquely bridges biochemical innovation with assay strategy, highlighting emerging implications for vascular, hepatic, and immune modulation studies.

• Cytochalasin D (SKU B6645): Reliable Actin Polymerization In

  2026-06-26

  This article explores how Cytochalasin D (SKU B6645) from APExBIO addresses real laboratory challenges in cell viability, proliferation, and cytotoxicity assays. Through scenario-driven Q&A, we demonstrate its reproducibility, potency, and workflow compatibility, supporting best practices for researchers seeking reliable actin polymerization inhibition.

• Cy3 Goat Anti-Rabbit IgG (H+L) Antibody: Precision in Immuno

  2026-06-26

  The Cy3 Goat Anti-Rabbit IgG (H+L) Antibody empowers high-sensitivity detection in immunofluorescence, IHC, and ICC by amplifying signal without sacrificing specificity. Seamlessly integrated into workflows studying mitochondrial dynamics and metabolic reprogramming, this Cy3-conjugated secondary antibody from APExBIO enables robust, reproducible imaging across complex biological models.

• Optimizing Live-Cell Golgi Imaging with Golgi-Tracker Green

  2026-06-25

  This article explores real-world laboratory challenges in live-cell Golgi apparatus imaging, sphingolipid metabolism analysis, and lipid transport studies, providing scenario-driven guidance on protocol design, troubleshooting, and vendor selection. Leveraging the specificity and photostability of Golgi-Tracker Green (SKU B8813), the discussion highlights practical solutions grounded in peer-reviewed evidence and product data, supporting reproducible and cost-efficient workflows in biomedical research.

• Acetylcysteine in 3D Tumor-Stroma Models: Redox Precision fo

  2026-06-25

  Explore mechanistic insights and strategic guidance for integrating Acetylcysteine (N-acetyl-L-cysteine, NAC) into advanced 3D co-culture models of chemoresistance. This article bridges oxidative stress modulation, stroma-driven drug resistance, and translational research innovation—delivering practical protocols, evidence-backed perspectives, and a vision for next-generation oncology workflows.

• Cinoxacin in Gram-Negative Research: Protocols & Pitfalls

  2026-06-24

  Cinoxacin’s precision as a quinolone antibiotic makes it an ideal tool for urinary tract infection and antibiotic resistance research. This article translates pivotal reference findings into reproducible workflows, troubleshooting strategies, and advanced comparative insights for Gram-negative bacterial assays.

• Adefovir (GS-0393): Applied Workflows for HBV Research Excel

  2026-06-23

  Adefovir (GS-0393) enables precise modeling of HBV DNA polymerase inhibition and OAT1-mediated renal transport—two pivotal axes in antiviral drug discovery. This article delivers actionable workflows, troubleshooting acumen, and evidence-based protocol parameters that empower laboratories to achieve reproducible, high-fidelity results with APExBIO’s Adefovir.

• Force-Threshold Modulation of Root Resorption via Nrf2/Keap1

  2026-06-23

  This study defines how the Nrf2/Keap1/p62 antioxidant pathway responds to varying orthodontic force magnitudes, linking mechanical stress to oxidative stress and inflammation in root resorption. Its findings reveal that Nrf2 is a mechanosensitive regulator, offering a precise molecular target for preventing orthodontically induced root resorption (OIRR).

• Magneto-Piezoelectric Scaffolds Activate JAK2-STAT3 for Bone

  2026-06-22

  Wu et al. engineered multifunctional scaffolds embedding magneto-piezoelectric nanoparticles to target Icam1+ macrophages in infectious bone defects. By activating oxidative phosphorylation through JAK2-STAT3 signaling and disrupting bacterial biofilms, this approach offers a dual mechanism for infection control and enhanced bone regeneration.

• Brain-to-Spinal Circuits Regulate Mechanical Allodynia Later

  2026-06-22

  This study systematically maps a brain-to-spinal circuit that controls both the laterality and duration of mechanical allodynia in mice. By delineating the roles of specific neuronal populations and their interactions, the work advances mechanistic understanding of bilateral pain hypersensitivity and offers a foundation for targeted preclinical research.

11881 records 3/793 page Previous Next 12345 下5页 Last page